Montelukast
- Generic Name
- Montelukast
- Brand Names
- Singulair
- Drug Type
- Small Molecule
- Chemical Formula
- C35H36ClNO3S
- CAS Number
- 158966-92-8
- Unique Ingredient Identifier
- MHM278SD3E
- Background
Montelukast was first approved for clinical use by the US FDA in 1998 as Merck's brand name Singulair. The medication is a member of the leukotriene receptor antagonist (LTRA) category of drugs. Although capable of demonstrating effectiveness, the use of such LTRAs like montelukast is typically in addition to or complementary with the use of inhaled corticos...
- Indication
Montelukast is indicated for:
...
- Associated Conditions
- Asthma, Exercise-Induced Bronchospasm, Perennial Allergic Rhinitis (PAR), Seasonal Allergic Rhinitis
- Associated Therapies
- -
Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children?
- First Posted Date
- 2015-08-27
- Last Posted Date
- 2019-08-22
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 60
- Registration Number
- NCT02534467
- Locations
- 🇦🇺
The Royal Children's Hospital, Parkville, Victoria, Australia
Cavernous Transformation of Portal Vein： Etiology, Diagnosis, Management and Prognosis
- Conditions
- Interventions
- First Posted Date
- 2015-07-22
- Last Posted Date
- 2015-10-29
- Lead Sponsor
- Sun Yat-sen University
- Target Recruit Count
- 150
- Registration Number
- NCT02505113
- Locations
- 🇨🇳
Department of Radiology, Guangzhou, Guangdong, China
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
- Conditions
- Interventions
- First Posted Date
- 2015-06-29
- Last Posted Date
- 2020-04-27
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 111
- Registration Number
- NCT02483975
- Locations
- 🇿🇦
GSK Investigational Site, Bellville, South Africa
Bioequivalence Study of Montelukast From Asmakast 5mg Chewable Tab.(Sandoz, Egypt) & Singulair 5mg Chewable Tab.(Merck)
- First Posted Date
- 2015-06-24
- Last Posted Date
- 2015-06-24
- Lead Sponsor
- Genuine Research Center, Egypt
- Target Recruit Count
- 24
- Registration Number
- NCT02479854
- Locations
- 🇪🇬
Genuine Research Center GRC, Cairo, Egypt
A Bioequivalence Study of Montelukast From Asmakast 10mg Tabs (Sandoz, Egypt) & Singulair 10mg Tabs (Merck)
- First Posted Date
- 2015-06-24
- Last Posted Date
- 2015-06-24
- Lead Sponsor
- Genuine Research Center, Egypt
- Target Recruit Count
- 26
- Registration Number
- NCT02480049
- Locations
- 🇪🇬
Genuine Research Center GRC, Cairo, Egypt
Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera
- Conditions
- Interventions
- First Posted Date
- 2015-04-07
- Last Posted Date
- 2020-03-31
- Lead Sponsor
- Biogen
- Target Recruit Count
- 102
- Registration Number
- NCT02410278
- Locations
- 🇺🇸
Research Site, Madison, Wisconsin, United States
CYP2B6 Genetics and Drug Interactions in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2015-03-27
- Last Posted Date
- 2017-10-11
- Lead Sponsor
- Indiana University
- Target Recruit Count
- 70
- Registration Number
- NCT02401256
- Locations
- 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States
Montelukast for Postinfectious Cough
- First Posted Date
- 2015-02-02
- Last Posted Date
- 2015-02-02
- Lead Sponsor
- Beijing Chao Yang Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT02352545
- Locations
- 🇨🇳
Kewu Huang, China, Beijing, China
Drug-Drug Interaction Study: ASP2151 and Montelukast
- First Posted Date
- 2014-12-22
- Last Posted Date
- 2019-02-27
- Lead Sponsor
- Maruho Europe Limited
- Target Recruit Count
- 24
- Registration Number
- NCT02321748
- Locations
- 🇬🇧
Hammersmith Medicines Research Ltd, London, United Kingdom
Fractional Concentration of Exhaled NO(FENO) to Direct Montelukast Treatment of Sub-acute Cough
- First Posted Date
- 2014-12-01
- Last Posted Date
- 2014-12-01
- Lead Sponsor
- Beijing Chao Yang Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT02303600
- Locations
- 🇨🇳
Beijing Chaoyang Hospital affiliated to Capital Medical University, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.